AMED News and Press, Amedisys Inc From 06/17/22

Gainers: AN2 Therapeutics (ANTX) +7%. Design Therapeutics (DSGN) +6%. Edgio (EGIO) +5%. Humacyte (HUMA) +5%. Rhythm Pharmaceuticals (RYTM) +5%. Losers: Swvl Holdings (SWVL) -10%. Amedisys (AMED) -8%. Lilium (LILM) -5%. Centessa Pharmaceuticals (CNTA) -5%. KLX Energy Services Holding...

BATON ROUGE, La., June 09, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, has released its first Environmental, Social and Governance (ESG) Report for the year 2021, detailing actions, achievements and ...

DALLAS and NASHVILLE, Tenn., June 09, 2022 (GLOBE NEWSWIRE) -- Baylor Scott & White Health, the largest not-for-profit health system in Texas, and Contessa, an Amedisys company (NASDAQ: AMED) and the nation's leading high-acuity home care provider, announce a partnership to provide pati...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

BATON ROUGE, La., May 19, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, has been selected by Modern Healthcare as one of the 2022 Best Places to Work in Healthcare for the second consecutive year. ...

The global home healthcare market could be worth nearly $635 billion by 2030, says Grand View Research, which could be a significant catalyst for companies such as Quipt Home Medical Corp. (NASDAQ: QIPT) (TSXV: QIPT), Amedisys Inc. (NASDAQ: AMED), LHC Group Inc. (NASDAQ: LHCG), ...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

BATON ROUGE, La., April 29, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Chris Gerard, President and Chief Executive Officer, and Scott Ginn, Executive Vice President and Chief Fi...

Amedisys, Inc. (AMED) Q1 2022 Earnings Conference Call April 28, 2022, 11:00 ET Company Participants Nick Muscato - Chief Strategy Officer Christopher Gerard - CEO, President & Director Scott Ginn - EVP & CFO David Kemmerly - Chief Legal & Government Affairs Officer Conference Cal...

Gainers: SQZ Biotechnologies (SQZ) +20%. Amedisys (AMED) +7%. Thermo Fisher Scientific (TMO) +7%. Vascular Biogenics (VBLT) +5%. Opiant Pharmaceuticals (OPNT) +4%. Losers: Teladoc Health (TDOC) -46%. Align Technology (ALGN) -23%. Aptorum Group (APM) -19...